ArthroCAD draws Series A for surgical device development

ArthroCAD nailed down the first part of a Series A funding round to help fuel development of a surgical device meant to improve outcomes for total hip arthroplasty procedures. The company isn't disclosing financial details other than to note that it has "secured commitments for additional funding" to complete the round. A number of investors took part, including Edgar D. Jannotta Jr., a former managing partner of the Chicago private equity firm GTCR. As part of the financing, he joins the board of ArthroCAD, which is based in Ayer, MA. Release

Suggested Articles

In an SEC filing, Baxter International disclosed that it may have overstated its income over multiple years, inflating it by about $276 million.

The FDA has given Grail a green light to conduct the interventional study, and it has begun enrolling participants through the company’s R&D partners.

Coronavirus may not require a front-line battle yet in certain places, but it’s still taxing public health officials preparing for a potential crisis.